Latest News

Learn about experimental drugs implanted in the eye that may enhance visual function, the genetic risks of developing glaucoma, how glaucoma can occur even when eye pressures is a normal range, and much more in the winter 2017 edition of the National Glaucoma Research Report.

An experimental drug, consisting of cells manufactured and implanted in the eye to stimulate optic nerve growth and activity, could be an entirely new way of fighting glaucoma.

BrightFocus is funding a clinical trial to try to fight glaucoma with a new drug implanted in the eye that may protect the optic nerve.

The fall 2016 edition of the National Glaucoma Research Report explores a study examining the effects of pressure fluctuations on glaucoma that may lead to new treatment approaches, explains why a dilated eye exam is a must, provides vision tips for winter driving, and more.

Learn about a new concept for restoring sight to damaged eyes, how researchers are turning a patients’ own cells into retinal ganglion cells, a discussion regarding the medical vs. surgical treatment of glaucoma, and more in the summer edition of our glaucoma newsletter.

Learn about research exploring the mechanisms of eye pressure regulation, which could lead to improved glaucoma treatments, five tips for using glaucoma eye drops, information about childhood glaucoma, and more in the winter edition of the winter edition of our glaucoma newsletter.

Explore the mystery of normal-tension glaucoma, a medication that may reduce the risk of open-angle glaucoma, learn about 15 new glaucoma research grants awarded by BrightFocus Foundation, and more in the fall edition of our glaucoma newsletter.

Download the summer 2015 issue of our glaucoma newsletter to learn about how a healthy diet leads to healthy eyes, how to make your computer vision-friendly, and much more.